RU2014130743A - Таблетки и средства с сухим покрытием - Google Patents

Таблетки и средства с сухим покрытием Download PDF

Info

Publication number
RU2014130743A
RU2014130743A RU2014130743A RU2014130743A RU2014130743A RU 2014130743 A RU2014130743 A RU 2014130743A RU 2014130743 A RU2014130743 A RU 2014130743A RU 2014130743 A RU2014130743 A RU 2014130743A RU 2014130743 A RU2014130743 A RU 2014130743A
Authority
RU
Russia
Prior art keywords
tablet
sodium
tablet according
disintegrant
component selected
Prior art date
Application number
RU2014130743A
Other languages
English (en)
Russian (ru)
Inventor
Масаки АНДО
Таканори ИТИХАСИ
Саяка КОДЗИМА
Масато САКУРАИ
Рина ТАНАКА
Original Assignee
Новартис Аг
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP2011284027A external-priority patent/JP2013133291A/ja
Priority claimed from JP2011284036A external-priority patent/JP2013133292A/ja
Application filed by Новартис Аг filed Critical Новартис Аг
Publication of RU2014130743A publication Critical patent/RU2014130743A/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/282—Organic compounds, e.g. fats
    • A61K9/2826—Sugars or sugar alcohols, e.g. sucrose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Zoology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
RU2014130743A 2011-12-26 2012-12-21 Таблетки и средства с сухим покрытием RU2014130743A (ru)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP2011-284036 2011-12-26
JP2011284027A JP2013133291A (ja) 2011-12-26 2011-12-26 錠剤
JP2011-284027 2011-12-26
JP2011284036A JP2013133292A (ja) 2011-12-26 2011-12-26 有核剤
PCT/EP2012/076794 WO2013098268A2 (en) 2011-12-26 2012-12-21 Tablets and dry-coated agents

Publications (1)

Publication Number Publication Date
RU2014130743A true RU2014130743A (ru) 2016-02-20

Family

ID=47436010

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2014130743A RU2014130743A (ru) 2011-12-26 2012-12-21 Таблетки и средства с сухим покрытием

Country Status (8)

Country Link
EP (1) EP2797580A2 (ja)
JP (1) JP2015504878A (ja)
KR (1) KR20140108652A (ja)
AU (1) AU2012360935A1 (ja)
BR (1) BR112014015620A8 (ja)
MX (1) MX2014007933A (ja)
RU (1) RU2014130743A (ja)
WO (1) WO2013098268A2 (ja)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI690333B (zh) * 2015-06-29 2020-04-11 日商大賽璐股份有限公司 易服用性固態製劑（有核錠）之製造方法及易服用性固態製劑
EP4243633A1 (en) * 2020-11-13 2023-09-20 Sila S.P.A. Orally dispersible compound containing an ester or salt of n-butyric acid and process for production
CN112826806A (zh) * 2021-01-20 2021-05-25 海南皇隆制药股份有限公司 一种缬沙坦片制备方法和缬沙坦片
CN112807286A (zh) * 2021-01-20 2021-05-18 海南皇隆制药股份有限公司 一种缬沙坦分散片制备方法和缬沙坦分散片

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE122010000024I1 (de) 1990-02-19 2010-07-08 Novartis Ag Acylverbindungen
JP3069458B2 (ja) 1992-01-29 2000-07-24 武田薬品工業株式会社 口腔内崩壊型錠剤およびその製造法
JP3122141B2 (ja) 1994-01-31 2001-01-09 山之内製薬株式会社 口腔内溶解型圧縮成型物及びその製造法
GB9613470D0 (en) 1996-06-27 1996-08-28 Ciba Geigy Ag Small solid oral dosage form
CA2311734C (en) * 2000-04-12 2011-03-08 Bristol-Myers Squibb Company Flash-melt oral dosage formulation
KR20040037138A (ko) * 2001-09-28 2004-05-04 가부시키가이샤산와카가쿠켄큐쇼 유핵형 속용붕괴성 성형품
WO2007052307A2 (en) * 2005-10-31 2007-05-10 Lupin Limited Stable solid oral dosage forms of valsartan
PE20120542A1 (es) * 2006-06-27 2012-05-14 Novartis Ag Formas de dosificacion solidas de valsartan, amlodipina e hidroclorotiazida y metodo para elaborarlas
MX2010003441A (es) * 2007-09-28 2010-04-21 Novartis Ag Formulaciones galenicas de alisquireno y valsartan.
JP2009114113A (ja) * 2007-11-06 2009-05-28 Nipro Corp 口腔内崩壊錠及びその製造方法
EP2222273A2 (en) * 2007-11-12 2010-09-01 Novartis AG Liquid compositions comprising valsartan
JP5296456B2 (ja) * 2008-08-26 2013-09-25 大日本住友製薬株式会社 溶出が良好なイルベサルタン含有医薬組成物および口腔内崩壊錠
WO2010065489A1 (en) * 2008-12-02 2010-06-10 Sciele Pharma, Inc. Alpha2-adrenergic agonist and angiotensin ii receptor antagonist composition
WO2010146551A2 (en) * 2009-06-16 2010-12-23 Ranbaxy Laboratories Limited Orally disintegrating compositions comprising antihypertensive agents
JP2013023463A (ja) * 2011-07-20 2013-02-04 Ohara Yakuhin Kogyo Kk 生理活性物質含有粒子の製造方法

Also Published As

Publication number Publication date
BR112014015620A2 (pt) 2017-06-13
BR112014015620A8 (pt) 2017-07-04
AU2012360935A1 (en) 2014-07-17
EP2797580A2 (en) 2014-11-05
JP2015504878A (ja) 2015-02-16
MX2014007933A (es) 2014-07-30
WO2013098268A3 (en) 2013-08-22
WO2013098268A2 (en) 2013-07-04
KR20140108652A (ko) 2014-09-12

Similar Documents

Publication Publication Date Title
AR069031A1 (es) Composicion
MD3892302T2 (ro) Compoziții care conțin Ibrutinib
RU2005115855A (ru) Композиция трамадола продлонгированного высвобождением с 24-часовым действием
RU2014130743A (ru) Таблетки и средства с сухим покрытием
FI3067043T3 (fi) Angiotensiinireseptoriantagonistin/-salpaajan (arb) ja neutraalin endopeptidaasin (nep) estäjän superrakenteisiin perustuvia farmaseuttisia koostumuksia
HRP20140780T4 (hr) Amorfni i kristalinični oblik genz 112638 hemitartrata kao inhibitor glukozilceramid sintaze
JO2641B1 (en) Pharmaceutical compounds containing calcium rosofastatin
JP2005538104A5 (ja)
UA116334C2 (uk) Тверді форми дозування бендамустину
JP2007197357A5 (ja)
MY146988A (en) Fexofenadine suspension formulation
WO2008129517A3 (en) A stabilized delayed release pharmaceutical composition of rabeprazole
NO20084276L (no) Orodispergerbare domperidontabletter
FI3573620T3 (fi) Koostumuksia kohonneen verenpaineen hoitamiseksi
JP2009541409A5 (ja)
JP2016108327A5 (ja)
WO2010012459A3 (en) A process for the preparation of solifenacin salts and their inclusion into pharmaceutical dosage forms
ES2534312T3 (es) Procedimiento de estabilización de un suplemento dietético que comprende glucosamina
WO2007007182A3 (en) Solid and liquid dosage forms of an antiepileptic agent
WO2005123098A3 (en) Preventing gastrointestinal side-effects with strontium salts
WO2006033505A8 (en) Paroxetine cholate or cholic acid derivative salts, and composition comprising paroxetine and cholic acid or cholic acid derivatives
ATE517612T1 (de) Rabeprazol-formulierung
WO2005051349A3 (en) Pharmaceutical compositions of mirtazapine
HRP20090102T3 (en) Improved pharmaceutical composition containing ace inhibitor and method for the preparation thereof
RU2006140307A (ru) Твердая дозированная лекарственная форма, повышающая физическую и умственную работоспособность

Legal Events

Date Code Title Description
FA92 Acknowledgement of application withdrawn (lack of supplementary materials submitted)

Effective date: 20170516